PT - JOURNAL ARTICLE AU - El-Saadani, Somaya AU - Saleh, Mohamed AU - Ibrahim, Sarah A. TI - Quantifying non-communicable diseases’ burden in Egypt using State-Space model AID - 10.1101/2021.01.07.21249383 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.07.21249383 4099 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249383.short 4100 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249383.full AB - The study aimed to model and quantify the health burden induced by four non-communicable diseases in Egypt, the first to be conducted in the context of a less developing county. The study used the State-Space model and adopted two Bayesian methods: Particle Filter and Particle Independent Metropolis-Hastings to model and estimate the NCDs’ health burden trajectories. We drew on time-series data of the International Health Metric Evaluation, CAPMAS’s Annual Bulletin of Health Services Statistics, the World Bank, and WHO data. Both Bayesian methods showed that the burden trajectories are on the rise. Most of the findings agreed with our assumptions and are in line with the literature. Previous year burden strongly predicts the burden of the current year. High prevalence of the risk factors, disease prevalence, and the disease’s severity level all increase illness burden. Years of life lost due to death has high loadings in most of the diseases. Contrary to the study assumption, results found a negative relationship between disease burden and health services utilization which can be attributed to the lack of full health insurance coverage and the pattern of health care seeking behavior in Egypt. Our study highlights that Particle Independent Metropolis-Hastings is sufficient in estimating the parameters of the study model, in the case of time-constant parameters. The study recommends using state Space models with Bayesian estimation approaches with time-series data in public health and epidemiology research.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trialsFunding StatementWe didn't receive any fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We didn't need IRB/oversight body approval or exemption for the research describedAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data of the study are available from public repository. WHO data are available in Global Health Observatory data repository at https://apps.who.int/gho/data/node.main.A867?lang=en. The Annual Health Services Statistical Bulletin are available at https://www.capmas.gov.eg/. The World Bank data were retrieved from World Bank Open data at https://data.worldbank.org/. The data of the institute of Health Metrics and Evaluation are available at http://ghdx.healthdata.org/record/ihme-data/gbd-2017-disability-weights, and http://ghdx.healthdata.org/gbd-results-tool. Data, R codes, and MATLAB codes are attached in supporting file S1 to reproduce the results. http://ghdx.healthdata.org/gbd-results-tool